Advertisement

Topics

PATH and WRAIR announce largest-ever controlled malaria infection

20:00 EDT 7 Sep 2017 | AAAS

(Burness) PATH's Malaria Vaccine Initiative and the US Department of Defense's Walter Reed Army Institute of Research announced today that vaccinations are under way in a clinical trial to evaluate modifications to the vaccine regimen of GSK's RTS,S/AS01 (RTS,S) malaria vaccine candidate. The partners seek to understand if these modifications will provide equal or increased protection compared to the standard pediatric regimen.

Original Article: PATH and WRAIR announce largest-ever controlled malaria infection

NEXT ARTICLE

More From BioPortfolio on "PATH and WRAIR announce largest-ever controlled malaria infection"

Quick Search
Advertisement
 

Relevant Topic

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...